Skip to content
  • Friday, 14 August 2026
  • 11:10 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • TWiV 1290: Clinical Update with Dr. Daniel Griffin Delves into Infectious Disease Trends and Public Health Strategies
Microbiology & Immunology

TWiV 1290: Clinical Update with Dr. Daniel Griffin Delves into Infectious Disease Trends and Public Health Strategies

Lina Irawan Jun 14, 2026 0

In his latest clinical update on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin provided a comprehensive overview…

Read More
Microbiology & Immunology

TWiV 1292: Clinical Update with Dr. Daniel Griffin Examines Public Health Decline, Vaccine Policy Shifts, and Resurgent Infectious Diseases

Lina Irawan May 11, 2026 0

In a recent clinical update on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin and host Vincent Racaniello…

Read More
Abacus AI Unveils Integrated Platform Revolutionizing Software Development Through AI-Powered Agent Collaboration and ‘Vibe Coding’Invasive goldfish trigger a regime shift in experimental lake ecosystems of varying trophic stateVirtual Heart Replicas Revolutionize Cardiac Rhythm Disorder Treatment, Pinpointing Faulty Beats and Accelerating ProceduresAncient Reptile Fossil Unveils Earliest Rib-Based Breathing System, Rewriting Evolutionary History
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ